Neural stem cell transplantation in central nervous system disorders: From cell replacement to neuroprotection

Current Opinion in Neurology

Volumn 25, Issue 3, 2012, Pages 322-333

  De Feo, Donatella ^a,b   Merlini, Arianna ^a,b   Laterza, Cecilia ^a   Martino, Gianvito ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Bystander effect; Cell replacement; Neural stem precursor cells; Neurodegeneration; Neuroinflammation; Therapeutic plasticity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DEATH RECEPTOR; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BYSTANDER EFFECT; CELL INTERACTION; CELL TRANSDIFFERENTIATION; CLINICAL EFFECTIVENESS; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; HUNTINGTON CHOREA; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MESENCHYMAL STEM CELL; MYELIN DEFICIENCY; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL TRANSPLANTATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; NUCLEAR REPROGRAMMING; PARKINSON DISEASE; PROTEIN EXPRESSION; REVIEW; SAFETY; SPINAL CORD INJURY; TISSUE INJURY; TISSUE REPAIR;

CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; NEURAL STEM CELLS; NEUROPROTECTIVE AGENTS; STEM CELL TRANSPLANTATION;

EID: 84860729847     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328352ec45     Document Type: Review

References (106)

1. Martino G, Pluchino S, Bonfanti L, Schwartz M. Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol Rev 2011; 91:1281-1304.
2. Martino G. How the brain repairs itself: new therapeutic strategies in inflammatory and degenerative CNS disorders. Lancet Neurol 2004; 3: 372-378.
3. Martino G, Adorini L, Rieckmann P, et al. Inflammation in multiple sclerosis: the good, the bad, and the complex. Lancet Neurol 2002; 1:499-509.
4. Martino G, Franklin RJ, Van Evercooren AB, Kerr DA. Stem cell transplantation in multiple sclerosis: current status and future prospects. Nat Rev Neurol 2010; 6:247-255.
5. Pera MF, Tam PP. Extrinsic regulation of pluripotent stem cells. Nature 2010; 465:713-720.
6. Uccelli A, Laroni A, Freedman MS. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol 2011; 10:649-656.
7. Korbling M, Estrov Z. Adult stem cells for tissue repair-a new therapeutic concept? N Engl J Med 2003; 349:570-582.
8. Boulis NM, Federici T, Glass JD, et al. Translational stem cell therapy for amyotrophic lateral sclerosis. Nat Rev Neurol 2011; 8:172-176.
9. Orchard PJ, Tolar J. Transplant outcomes in leukodystrophies. Semin Hematol 2010; 47:70-78.
10. Mancardi G, Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol 2008; 7:626-636.
11. Atkins HL, Muraro PA, van Laar JM, Pavletic SZ. Autologous hematopoietic stem cell transplantation for autoimmune disease-is it now ready for prime time? Biol Blood Marrow Transplant 2012; 18:S177-S183.
12. Rovo A, Gratwohl A. Plasticity after allogeneic hematopoietic stem cell transplantation. Biol Chem 2008; 389:825-836.
13. Massengale M, Wagers AJ, Vogel H, Weissman IL. Hematopoietic cells maintain hematopoietic fates upon entering the brain. J Exp Med 2005; 201:1579-1589.
14. Sigurjonsson OE, Perreault MC, Egeland T, Glover JC. Adult human hematopoietic stem cells produce neurons efficiently in the regenerating chicken embryo spinal cord. Proc Natl Acad Sci USA 2005; 102:5227-5232.
15. Uccelli A, Morando S, Bonanno S, et al. Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter? Curr Stem Cell Res Ther 2011; 6:69-72.
16. Sauka-Spengler T, Bronner-Fraser M. A gene regulatory network orchestrates neural crest formation. Nat Rev Mol Cell Biol 2008; 9:557-568.
17. Hochstim C, Deneen B, Lukaszewicz A, et al. Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code. Cell 2008; 133:510-522.
18. Eroglu C, Barres BA. Regulation of synaptic connectivity by glia. Nature 2010; 468:223-231.
19. Ingber DE, Levin M. What lies at the interface of regenerative medicine and developmental biology? Development 2007; 134:2541-2547.
20. Poss KD. Advances in understanding tissue regenerative capacity and mechanisms in animals. Nat Rev Genet 2010; 11:710-722.
21. Gaillard A, Jaber M. Rewiring the brain with cell transplantation in Parkinson's disease. Trends Neurosci 2011; 34:124-133.
22. Buhnemann C, Scholz A, Bernreuther C, et al. Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain 2006; 129:3238-3248.
23. Kelly S, Bliss TM, Shah AK, et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci USA 2004; 101:11839-11844.
24. Sahni V, Kessler JA. Stem cell therapies for spinal cord injury. Nat Rev Neurol 2010; 6:363-372.
25. Lepore AC, O'Donnell J, Kim AS, et al. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS One 2011; 6:e25968.
26. Pluchino S, Quattrini A, Brambilla E, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003; 422:688-694.
27. Pluchino S, Zanotti L, Rossi B, et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005; 436:266-271.
28. Bacigaluppi M, Pluchino S, Peruzzotti-Jametti L, et al. Delayed postischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 2009; 132:2239-2251.
29. Cusimano M, Biziato D, Brambilla E, et al. Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord. Brain 2012; 135:447-460.
30. Einstein O, Karussis D, Grigoriadis N, et al. Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis. Mol Cell Neurosci 2003; 24:1074-1082.
31. Lee ST, Chu K, Jung KH, et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008; 131: 616-629.
32. Ziv Y, Avidan H, Pluchino S, et al. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci USA 2006; 103:13174-13179.
33. Einstein O, Fainstein N, Vaknin I, et al. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann Neurol 2007; 61:209-218.
34. Pluchino S, Zanotti L, Brambilla E, et al. Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function. PLoS One 2009; 4:e5959.
35. Cao W, Yang Y, Wang Z, et al. Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease. Immunity 2011; 35:273-284.
36. Pluchino S, Gritti A, Blezer E, et al. Human neural stem cells ameliorate autoimmune encephalomyelitis in nonhuman primates. Ann Neurol 2009; 66:343-354.
37. Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003; 181:115-129.
38. Teng YD, Lavik EB, Qu X, et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA 2002; 99:3024-3029.
39. Chu K, Kim M, Park KI, et al. Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia. Brain Res 2004; 1016:145-153.
40. Redmond DE Jr, Bjugstad KB, Teng YD, et al. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA 2007; 104:12175-12180.
41. Lepore AC, Rauck B, Dejea C, et al. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 2008; 11:1294-1301.
42. LindvallO, Kokaia Z. Stem cells in human neurodegenerative disorders-time for clinical translation? J Clin Invest 2010; 120:29-40.
43. Ryu JK, Kim J, Cho SJ, et al. Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease. Neurobiol Dis 2004; 16:68-77.
44. Aharonowiz M, Einstein O, Fainstein N, et al. Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS One 2008; 3:e3145.
45. Einstein O, Friedman-Levi Y, Grigoriadis N, Ben-Hur T. Transplanted neural precursors enhance host brain-derived myelin regeneration. J Neurosci 2009; 29:15694-15702.
46. Cao Q, He Q, Wang Y, et al. Transplantation of ciliary neurotrophic factorexpressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J Neurosci 2010; 30:2989-3001.
47. Jaderstad J, Jaderstad LM, Li J, et al. Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host. Proc Natl Acad Sci USA 2010; 107:5184-5189.
48. Ben-Hur T, Goldman SA. Prospects of cell therapy for disorders of myelin. Ann N Y Acad Sci 2008; 1142:218-249.
49. Giannakopoulou A, Grigoriadis N, Polyzoidou E, et al. Time-dependent fate of transplanted neural precursor cells in experimental autoimmune encephalomyelitis mice. Exp Neurol 2011; 230:16-26.
50. Kim J, Efe JA, Zhu S, et al. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci USA 2011; 108:7838-7843.
51. Dunnett SB, Whishaw IQ, Rogers DC, Jones GH. Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions. Brain Res 1987; 415:63-78.
52. Starr PA, Wichmann T, van Horne C, Bakay RA. Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey. Cell Transplant 1999; 8:37-45.
53. Isacson O, Deacon TW. Specific axon guidance factors persist in the adult brain as demonstrated by pig neuroblasts transplanted to the rat. Neuroscience 1996; 75:827-837.
54. Wictorin K, Brundin P, Sauer H, et al. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. J Comp Neurol 1992; 323:475-494.
55. Shim JW, Park CH, Bae YC, et al. Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression. Stem Cells 2007; 25:1252-1262.
56. Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 2008; 105:5856-5861.
57. Duncan ID, Kondo Y, Zhang SC. The myelin mutants as models to study myelin repair in the leukodystrophies. Neurotherapeutics 2011; 8:607-624.
58. Ben-Hur T, Einstein O, Bulte JW. Stem cell therapy for myelin diseases. Curr Drug Targets 2005; 6:3-19.
59. Blakemore WF, Franklin RJ. Remyelination in experimental models of toxininduced demyelination. Curr Top Microbiol Immunol 2008; 318:193-212.
60. Windrem MS, Nunes MC, Rashbaum WK, et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 2004; 10:93-97.
61. Buchet D, Garcia C, Deboux C, et al. Human neural progenitors from different foetal forebrain regions remyelinate the adult mouse spinal cord. Brain 2011; 134:1168-1183.
62. Sim FJ, McClain CR, Schanz SJ, et al. CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells. Nat Biotechnol 2011; 29: 934-941.
63. Daadi MM, Li Z, Arac A, et al. Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther 2009; 17:1282-1291.
64. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci USA 2005; 102:14069-14074.
65. Yan J, Xu L, Welsh AM, et al. Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. PLoS Med 2007; 4:e39.
66. Yohn DC, Miles GB, Rafuse VF, Brownstone RM. Transplanted mouse embryonic stem-cell-derived motoneurons form functional motor units and reduce muscle atrophy. J Neurosci 2008; 28:12409-12418.
67. DiGiorgio FP, CarrascoMA, Siao MC, et al. Noncell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 2007; 10:608-614.
68. Verstraete E, Veldink JH, Mandl RC, et al. Impaired structural motor connectome in amyotrophic lateral sclerosis. PLoS One 2011; 6:e24239.
69. Wolf RC, Sambataro F, Vasic N, et al. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp Neurol 2008; 213:137-144.
70. Solodkin A, Peri E, Chen EE, et al. Loss of intrinsic organization of cerebellar networks in spinocerebellar ataxia type 1: correlates with disease severity and duration. Cerebellum 2011; 10:218-232.
71. Shihabuddin LS, Holets VR, Whittemore SR. Selective hippocampal lesions differentially affect the phenotypic fate of transplanted neuronal precursor cells. Exp Neurol 1996; 139:61-72.
72. Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 2005; 23:862-871.
73. Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97:12846-12851.
74. Rampon C, Weiss N, Deboux C, et al. Molecular mechanism of systemic delivery of neural precursor cells to the brain: assembly of brain endothelial apical cups and control of transmigration by CD44. Stem Cells 2008; 26:1673-1682.
75. Ji JF, He BP, Dheen ST, Tay SS. Expression of chemokine receptors CXCR4, CCR2, CCR5 and CX3CR1 in neural progenitor cells isolated from the subventricular zone of the adult rat brain. Neurosci Lett 2004; 355:236-240.
76. Campos LS, Decker L, Taylor V, Skarnes W. Notch, epidermal growth factor receptor, and beta1-integrin pathways are coordinated in neural stem cells. J Biol Chem 2006; 281:5300-5309.
77. Campos LS, Leone DP, Relvas JB, et al. Beta1 integrins activate a MAPK signalling pathway in neural stem cells that contributes to their maintenance. Development 2004; 131:3433-3444.
78. Pluchino S, Cusimano M, Bacigaluppi M, Martino G. Remodelling the injured CNS through the establishment of atypical ectopic perivascular neural stem cell niches. Arch Ital Biol 2010; 148:173-183.
79. Seifert T, Bauer J, Weissert R, et al. Differential expression of sonic hedgehog immunoreactivity during lesion evolution in autoimmune encephalomyelitis. J Neuropathol Exp Neurol 2005; 64:404-411.
80. Irvin DK, Nakano I, Paucar A, Kornblum HI. Patterns of Jagged1, Jagged2, Delta-like 1 and Delta-like 3 expression during late embryonic and postnatal brain development suggest multiple functional roles in progenitors and differentiated cells. J Neurosci Res 2004; 75:330-343.
81. Nicoleau C, Viegas P, Peschanski M, Perrier AL. Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges. Neurotherapeutics 2011; 8:562-576.
82. Martino G, Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci 2006; 7:395-406.
83. Windpassinger C, Schoser B, Straub V, et al. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 2008; 82:88-99.
84. Butzkueven H, Zhang JG, Soilu-Hanninen M, et al. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 2002; 8:613-619.
85. Marriott MP, Emery B, Cate HS, et al. Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair. Glia 2008; 56:686-698.
86. Andres RH, Horie N, Slikker W, et al. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 2011; 134:1777-1789.
87. Zeng H, Guo M, Martins-Taylor K, et al. Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. PLoS One 2010; 5:e11853.
88. Swistowski A, Peng J, Liu Q, et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 2010; 28:1893-1904.
89. Pouya A, Satarian L, Kiani S, et al. Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination. PLoS One 2011; 6: e27925.
90. Ogawa S, Tokumoto Y, Miyake J, Nagamune T. Immunopanning selection of A2B5-positive cells increased the differentiation efficiency of induced pluripotent stem cells into oligodendrocytes. Neurosci Lett 2011; 489:79-83.
91. Ogawa S, Tokumoto Y, Miyake J, Nagamune T. Induction of oligodendrocyte differentiation from adult human fibroblast-derived induced pluripotent stem cells. In Vitro Cell Dev Biol Anim 2011; 47:464-469.
92. Wu SM, Hochedlinger K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol 2011; 13: 497-505.
93. Caiazzo M, Dell'Anno MT, Dvoretskova E, et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 2011; 476:224-227.
94. Yoo AS, Sun AX, Li L, et al. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 2011; 476:228-231.
95. Patrikios P, Stadelmann C, Kutzelnigg A, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006; 129:3165-3172.
96. Bramow S, Frischer JM, Lassmann H, et al. Demyelination versus remyelination in progressive multiple sclerosis. Brain 2010; 133:2983-2998.
97. Darsalia V, Allison SJ, Cusulin C, et al. Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cereb Blood Flow Metab 2011; 31:235-242.
98. Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci 2009; 10:861-872.
99. Southwell DG, Froemke RC, Alvarez-Buylla A, et al. Cortical plasticity induced by inhibitory neuron transplantation. Science 2010; 327:1145-1148.
100. Thirabanjasak D, Tantiwongse K, Thorner PS. Angiomyeloproliferative lesions following autologous stem cell therapy. J Am Soc Nephrol 2010; 21:1218-1222.
101. Melzi R, Antonioli B, Mercalli A, et al. Co-graft of allogeneic immune regulatory neural stem cells (NPC) and pancreatic islets mediates tolerance, while inducing NPC-derived tumors in mice. PLoS One 2010; 5:e10357.
102. Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009; 6:e1000029.
103. Fazel SS, Angoulvant D, Butany J, et al. Mesenchymal stem cells engineered to overexpress stem cell factor improve cardiac function but have malignant potential. J Thorac Cardiovasc Surg 2008; 136:1388-1389.
104. Jeong JO, Han JW, Kim JM, et al.Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res 2011; 108:1340-1347.
105. Aboody K, Capela A, Niazi N, et al. Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta Stone. Neuron 2011; 70:597-613.
106. Trounson A, Thakar RG, Lomax G, Gibbons D. Clinical trials for stem cell therapies. BMC Med 2011; 9:52.